Pyrazolopyridines as phosphodiesterase inhibitors for respiratory disease
Synthetic chemistry was explored to expand a series of 6-(pyrazolo[1,5-a]pyridin-3-yl)-2Hpyridazin- 3-one phosphodiesterase (PDE) inhibitors with therapeutic potential for treatment of asthma. The synthetic route to these compounds featured a 1,3-dipolar cycloaddition reaction between a pyridine N-i...
Main Author: | Blakli, Haakon |
---|---|
Published: |
Heriot-Watt University
2007
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.490952 |
Similar Items
-
Studies on the Inhibitors of Cyclic Nucleotide Phosphodiesterases Produced by Streptomyces
by: Furutani, Yoshio
Published: (2017) -
Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
by: Theerasuk Kawamatawong
Published: (2021-08-01) -
Doebner-type pyrazolopyridine carboxylic acids in an Ugi four-component reaction
by: Maryna V. Murlykina, et al.
Published: (2019-06-01) -
Phosphodiesterase 4 inhibitors for the treatment of inflammation associated with respiratory disease
by: Cooper, Nicola
Published: (2010) -
Efficient synthesis of pyrazolopyridines containing a chromane backbone through domino reaction
by: Razieh Navari, et al.
Published: (2019-04-01)